Published in J Neurol Neurosurg Psychiatry on September 01, 2002
Gap junctions couple astrocytes and oligodendrocytes. J Mol Neurosci (2008) 1.16
Gap junctions in inherited human disorders of the central nervous system. Biochim Biophys Acta (2011) 1.05
Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations. J Neurol (2008) 1.01
X-linked Charcot-Marie-Tooth disease and multiple sclerosis. J Neurol (2007) 0.91
How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Brain Res (2012) 0.87
Two tyrosine-based sorting signals in the Cx43 C-terminus cooperate to mediate gap junction endocytosis. Mol Biol Cell (2013) 0.87
A zebrafish model for Waardenburg syndrome type IV reveals diverse roles for Sox10 in the otic vesicle. Dis Model Mech (2008) 0.87
A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot-Marie-Tooth disease. J Neurol (2010) 0.85
Episodic neurological dysfunction in hereditary peripheral neuropathy. Ann Indian Acad Neurol (2015) 0.83
Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease. BMC Neurol (2007) 0.78
A new mutation in GJC2 associated with subclinical leukodystrophy. J Neurol (2014) 0.76
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease. Acta Neuropathol Commun (2016) 0.75
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet (1999) 4.17
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet (1992) 3.55
Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology (2005) 3.44
The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Myasthenia gravis. Lancet (2001) 2.82
A randomised controlled trial. Shifting boundaries of doctors and physiotherapists in orthopaedic outpatient departments. J Epidemiol Community Health (1999) 2.76
Family size and the quality of children. Demography (1981) 2.73
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain (1992) 2.62
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology (2012) 2.56
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet (1991) 2.36
Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology (2008) 2.31
Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol (2011) 2.30
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med (1998) 2.20
Social costs of untreated opioid dependence. J Urban Health (2000) 2.18
Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet (1995) 2.17
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Eye injuries in road traffic accidents. Ir Med J (1983) 2.03
Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol (2010) 2.03
The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol (2012) 2.03
5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem (1999) 2.00
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84
The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J Neurol Neurosurg Psychiatry (2008) 1.84
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80
SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Neurology (2008) 1.79
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
Abortion and public opinion: the 1960-1970 decade. Science (1971) 1.77
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet (2001) 1.72
Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology (2003) 1.71
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
Genetic association studies: genes in search of diseases. Neurology (2001) 1.65
An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood (1974) 1.65
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
The phenotypic manifestations of chromosome 17p11.2 duplication. Brain (1997) 1.63
Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
The use of adenosine deaminase assays in the diagnosis of tuberculosis. S Afr Med J (1982) 1.59
Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet (1986) 1.57
The British Isles survey of multiple sclerosis in twins. Neurology (1994) 1.57
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
Road blindness. Br Med J (Clin Res Ed) (1983) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences. J Biol Chem (1997) 1.55
PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology (2004) 1.49
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol (2000) 1.47
Population policy for Americans: is the government being misled? Science (1969) 1.46
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44
Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ (2008) 1.44
A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet (1992) 1.40
Prenatal diagnosis of mitochondrial DNA8993 T----G disease. Am J Hum Genet (1992) 1.38
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. Neurology (2005) 1.38
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet (1996) 1.38
Peptide segment coupling in aqueous medium: silver ion activation of the thiolcarboxyl group. Int J Pept Protein Res (1981) 1.33
Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatry (1992) 1.33
A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nat Genet (1993) 1.31
Frequency-narrowed external-cavity diode-laser-array bar. Opt Lett (2000) 1.27
Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet (1994) 1.26
A new hepadnavirus endemic in arctic ground squirrels in Alaska. J Virol (1996) 1.26
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling. J Immunol (1992) 1.22
Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest (1992) 1.22
The synthesis and biological activity of (165, 182, 189-S-carbamidomethylcysteine)-human growth hormone-(140-191). Int J Pept Protein Res (1975) 1.22
SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology (2006) 1.22
Failure of postural manoeuvres to prevent lumbar puncture headache. J Neurol Neurosurg Psychiatry (1982) 1.20
A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am J Hum Genet (1999) 1.20
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol (2001) 1.20
Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry (1995) 1.20
Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol (2006) 1.19
What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed. Neurology (2008) 1.19
Eye injuries in agriculture. J Ir Med Assoc (1971) 1.19
Trinucleotide repeats and neurodegenerative disease. Brain (2004) 1.19
Mitochondrial gene defects in patients with NIDDM. Diabetologia (1994) 1.18
Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav (1996) 1.17
Topological mapping of acetylcholine receptor: evidence for a model with five transmembrane segments and a cytoplasmic COOH-terminal peptide. Proc Natl Acad Sci U S A (1985) 1.16
Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother (1991) 1.15